| Name | Title | Contact Details |
|---|
Alturas Analytics is a Moscow, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Mary`s Health Care System is a not-for-profit Catholic health care provider whose mission is to be a compassionate healing presence in the communities we serve. Founded in 1906 and sponsored by the Sisters of Mercy, St. Mary`s Health Care System is built on a foundation of values that include excellence, compassion, integrity and reverence for each person. St. Mary`s focuses on neurosciences, cardiac care, orthopedics, general medicine/general surgery, women`s and children`s health, and gastroenterology. The system includes 196-bed St. Mary`s Hospital in Athens and 25-bed St. Mary`s Good Samaritan Hospital in Greene County. Services include emergency care, intensive care, home health care/hospice services, inpatient and outpatient rehabilitation, assisted living, Alzheimer`s/dementia care, preventive care, state-of-the art diagnostic and therapeutic care and a growing network of physician practices. Named Georgia`s Hospital of the Year in 2006 and 2010, St. Mary`s is proud to be the official health care provider for the University of Georgia Athletic Association. St. Mary`s has earned the Joint Commission Gold Seal of Approval for advanced primary stroke care, advanced inpatient diabetes, heart failure care, knee replacement surgery and spine surgery.
Pointe Scientific is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.
EvidenceCare is the only decision support tool designed exclusively for clinicians that delivers evidence-based medicine individualized for each patient they treat. Our patent pending technology lowers costs and improves outcomes in a way that benefits patients, providers, payers, and clinics. We provide the evidence, so you can provide the care.